Glass Mitchell
SEC insider (Form 3/4/5 filer). CIK 0002023649. Chief Medical Officer at Q/C TECHNOLOGIES, INC. (QCLS). 4 reported Form 4/5 transactions since Sep 2024; latest on Apr 13, 2026. Located in NEW YORK, NY.
Companies Glass Mitchell has filed insider reports for
- Q/C TECHNOLOGIES, INC. (QCLS): Director, Officer, Chief Medical Officer
Glass Mitchell
CIK: 0002023649
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
QCLS
Q/C TECHNOLOGIES, INC.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Apr 13, 2026QCLS
Q/C TECHNOLOGIES, INC.
AwardDirectEmployee Stock Option (Right to Buy)
50K shares- - Nov 14, 2025QCLS
Q/C TECHNOLOGIES, INC.
AwardDirect11.4K shares- - Oct 3, 2025QCLS
Q/C TECHNOLOGIES, INC.
AwardDirect1.1K shares- - Apr 17, 2025TNFA
TNF Pharmaceuticals, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
125K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 13, 2026 | QCLS Q/C TECHNOLOGIES, INC. | Award Employee Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Nov 14, 2025 | QCLS Q/C TECHNOLOGIES, INC. | Award | 11,420 | - | - | Direct |
| Oct 3, 2025 | QCLS Q/C TECHNOLOGIES, INC. | Award | 1,080 | - | - | Direct |
| Apr 17, 2025 |  TNFA TNF Pharmaceuticals, Inc. | Award Employee Stock Option (Right to Buy) | 125,000 | - | - | Direct |
1-4 of 4 transactions